SAPHNELO

Google image searchProduct monograph

Active ingredient

anifrolumab, 150 MG/ML

DIN: 02522845

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: ASTRAZENECA CANADA INC

Date: 01-MAR-2022

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AG — Monoclonal antibodies (ATC, ATC/DDD)
• L04AG11 — ANIFROLUMAB (ATC/DDD)

External Links for Saphnelo

Search on Google

• Saphnelo side effects
• Saphnelo dosage
• anifrolumab side effects
• anifrolumab dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find saphnelo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.